Expired Tender USA ICB TOT Ref. 125225634

Aging Mammalian Tissues In Vitro (R21 Clinical Tender - 125225634

Tender notice from USA, published on 27 Aug 2025.

Executive Summary

The NATIONAL INSTITUTES OF HEALTH has issued a Tender notice for the procurement of a Aging Mammalian Tissues In Vitro (R21 Clinical Trial Not Allowed) in the USA. This Tender notice was published on 27 Aug 2025 and is scheduled to close on 20 Oct 2025, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 125225634, while the tender notice number is RFA-AG-26-014 and Register on the platform.

Key facts

Summary
Aging Mammalian Tissues In Vitro (R21 Clinical Trial Not Allowed)
TOT Ref. No.
125225634
Document Ref. No.
RFA-AG-26-014
Country
USA
Notice type
Tender
Competition
ICB
Publication date
27 Aug 2025
Bid deadline
20 Oct 2025
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

This Notice Of Funding Opportunity (Nofo) Invites Applications That Propose Interdisciplinary Research That Aims To Develop Complex Mammalian 3-Dimensional (3D)In Vitromicrophysiological Systems (Mps) To Model Aging And Recapitulate Aging Processes/Phenotypes Observed In The Whole Organismin Vivo. This Nofo Is Primarily Focused On Human Cell-Derived Mps (E.G., Tissue Chip, Organ-On-Chip, Tissue Organoids). However, Systems Developed Using Cells Of Nonhuman Mammalian Origin Are Acceptable For Benchmarking, System Validation, Or When Their Relevance To Understanding Human Aging Biology Is Justified. Supported Projects Will Be Expected To Advance The Adoption Of Mps In Aging Biology Research And As New Human-Relevant Tools For Drug Discovery. This Nofo Uses The R21 Activity Code, Which Is Intended For Exploratory Research At The Early And Conceptual Stages Of Project Development. Preliminary Data Are Not Required. An Essential Feature Of Responsive Applications Is The Adoption Of A Multidisciplinary Approach That Includes Expertise In Aging Biology And From Disciplines Such As Stem Cell Biology, Tissue And Organ Physiology, Microfluidics, Bioengineering, Computational Biology, Pharmacology, And Biostatistics.
Opportunity Category : Discretionary

Opportunity Category Explanation :

Funding Instrument Type : Grant

Category of Funding Activity : Health

CFDA_Number :
Posted Date : Aug 26, 2025

Last Updated Date : Aug 26, 2025

Documents

Tender Notice
Login to view

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for Aging Mammalian Tissues In Vitro (R21 Clinical Trial Not Allowed) was 20 Oct 2025. Bidding is closed.

This tender has been issued by NATIONAL INSTITUTES OF HEALTH in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 125225634. The purchaser document reference is RFA-AG-26-014.

Browse other tenders from USA or search by relevant keywords and CPV classification.